Muscle cells enhance resistance to pro-inflammatory cytokine-induced cartilage destruction

Biochemical and Biophysical Research Communications

Volumn 392, Issue 1, 2010, Pages 22-28

  Cairns, Dana M ^a   Uchimura, Tomoya ^b   Kwon, Heenam ^a   Lee, Philip G ^b   Seufert, Christopher R ^b   Matzkin, Elizabeth ^c   Zeng, Li ^a,b,c  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Cartilage; Matrix; Muscle; Pro inflammatory cytokines

Indexed keywords

COLLAGEN TYPE 2; CYCLOOXYGENASE 2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; ARTICLE; CARTILAGE CELL; CELL STRAIN 3T3; COCULTURE; CYTOKINE PRODUCTION; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAM PROTEINS; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, DIFFERENTIATION; CARTILAGE, ARTICULAR; CHONDROCYTES; COCULTURE TECHNIQUES; COLLAGEN; CYCLOOXYGENASE 2; INTERLEUKIN-1BETA; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MICE; MYOBLASTS; NF-KAPPA B; NIH 3T3 CELLS; OSTEOARTHRITIS; PROCOLLAGEN N-ENDOPEPTIDASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74849116301     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.138     Document Type: Article

References (36)

1. Sandell L.J., and Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 3 (2001) 107-113
2. Goldring M.B., Otero M., Tsuchimochi K., et al. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann. Rheum. Dis. 67 Suppl. 3 (2008) iii75-iii82
3. Blaschke U.K., Eikenberry E.F., Hulmes D.J., et al. Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J. Biol. Chem. 275 (2000) 10370-10378
4. Mastbergen S.C., Jansen N.W., Bijlsma J.W., et al. Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study. Arthritis Res. Ther. 8 (2006) R2
5. Peng H., Tan L., Osaki M., et al. ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J. Cell. Physiol. 215 (2008) 562-573
6. Ijiri K., Zerbini L.F., Peng H., et al. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J. Biol. Chem. 280 (2005) 38544-38555
7. Buckingham M., Bajard L., Chang T., et al. The formation of skeletal muscle: from somite to limb. J. Anat. 202 (2003) 59-68
8. Kubota E., Kubota T., Matsumoto J., et al. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J. Oral. Maxillofac. Surg. 56 (1998) 192-198
9. Drachman D., and Sokoloff L. The role of movement in embryonic joint development. Dev. Biol. 14 (1966) 401
10. Deconinck A.E., Rafael J.A., Skinner J.A., et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90 (1997) 717-727
11. Knapp J.R., Davie J.K., Myer A., et al. Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size. Development 133 (2006) 601-610
12. Oustanina S., Hause G., and Braun T. Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J. 23 (2004) 3430-3439
13. Rapaport D., Colletto G.M., Vainzof M., et al. Short stature in Duchenne muscular dystrophy. Growth Regul. 1 (1991) 11-15
14. Eiholzer U., Boltshauser E., Frey D., et al. Short stature: a common feature in Duchenne muscular dystrophy. Eur. J. Pediatr. 147 (1988) 602-605
15. D. Cairns, P. Lee, T. Uchimura, et al., The role of muscle cells in regulating cartilage matrix production, J. Orthop. Res., 7 Oct. 2009 [Epub ahead of print].
16. Nielsen S., and Pedersen B.K. Skeletal muscle as an immunogenic organ. Curr. Opin. Pharmacol. 8 (2008) 346-351
17. Goetsch S.C., Hawke T.J., Gallardo T.D., et al. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol. Genomics 14 (2003) 261-271
18. Sun G.L., Zhao S., Li P., and Jiang H.K. Expression of tissue inhibitor of metalloproteinase-1 in progression muscular dystrophy. Neurosci. Bull. 22 (2006) 85-90
19. Zanoteli E., Guimaraes A.S., Martins R.J., et al. Temporomandibular joint involvement in a patient with centronuclear myopathy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90 (2000) 118-121
20. Slemenda C., Heilman D.K., Brandt K.D., et al. Reduced quadriceps strength relative to body weight: a risk factor for knee osteoarthritis in women?. Arthritis Rheum. 41 (1998) 1951-1959
21. Abramoff M., Magelhaes P., and Ram S. Image processing with ImageJ. Biophotonics Int. 11 (2004) 36-42
22. Krejci P., Masri B., Fontaine V., et al. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J. Cell Sci. 118 (2005) 5089-5100
23. Andres V., and Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132 (1996) 657-666
24. Goldring M.B., and Goldring S.R. Osteoarthritis. J. Cell. Physiol. 213 (2007) 626-634
25. Goldring M.B., and Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin. Orthop. Relat. Res. (2004) S37-46
26. Sandell L.J., Xing X., Franz C., et al. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage 16 (2008) 1560-1571
27. Hui W., Cawston T., and Rowan A.D. Transforming growth factor beta 1 and insulin-like growth factor 1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor alpha from bovine cartilage. Ann. Rheum. Dis. 62 (2003) 172-174
28. Hui W., Rowan A.D., and Cawston T. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha. Cytokine 16 (2001) 31-35
29. Im H.J., Pacione C., Chubinskaya S., et al. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J. Biol. Chem. 278 (2003) 25386-25394
30. Gouze J.N., Gouze E., Popp M.P., et al. Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta. Arthritis Res. Ther. 8 (2006) R173
31. Jomphe C., Gabriac M., Hale T.M., Heroux L., Trudeau L.E., Deblois D., Montell E., Verges J., and du Souich P. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes. Basic Clin. Pharmacol. Toxicol. 102 (2008) 59-65
32. + adult stem cells during muscle regeneration. Cell 113 (2003) 841-852
33. Kislinger T., Gramolini A.O., Pan Y., et al. Proteome dynamics during C2C12 myoblast differentiation. Mol. Cell. Proteomics 4 (2005) 887-901
34. Chan X.C., McDermott J.C., and Siu K.W. Identification of secreted proteins during skeletal muscle development. J. Proteome Res. 6 (2007) 698-710
35. Goldring M.B., Birkhead J.R., Suen L.F., et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94 (1994) 2307-2316
36. Sandell L.J. Anabolic factors in degenerative joint disease. Curr. Drug Targets 8 (2007) 359-365